Nautilus Neurosciences Inc., Tribute Pharmaceuticals sales and marketing update

Nautilus granted Tribute an exclusive license to develop and commercialize Cambia diclofenac powder in Canada. Tribute will be responsible for obtaining Canadian regulatory approval for the oral form...